Yale VAMOS Program Provides Holistic Vascular Care
The Vascular Medicine OutcomeS (VAMOS) program at Yale University, an integral program supported by the Yale New Haven Health’s Heart and Vascular Center and Center for Musculoskeletal Care, includes a global team of interventional cardiologists, vascular surgeons, podiatrists, radiologists, allied health professionals, and outcomes researchers committed to transforming how PAD is diagnosed and treated, and how patients access care.
Real-world outcomes study targets patients undergoing intravascular lithotripsy treatment at Yale
An observational study at the Heart and Vascular Center (HVC) at Yale New Haven Hospital (YNHH) Heart and Vascular Center could have major implications for patients with peripheral artery disease or PAD.
“Complete Academic Physician” Dr. Karl Insogna Retires From Clinical Duties
During his childhood in Wolcott, Conn., Karl Insogna’s parents instilled in him a few life lessons. Insogna, MD, FACP, Ensign Professor of Medicine (Endocrinology); director, Yale Bone Center; and associate director, Yale Center for X-Linked Hypophosphatemia; was taught to strive to leave the world a better place than you found it, and to do something to help others.
Africa on the Global Stage: Analyzing 30 Years of African-Led Clinical Trials in Cardiovascular Medicine
In order to understand the limitations faced by African investigators in modern cardiology research, a group of researchers, led by Internal Medicine Resident Abdelrahman Abushouk, MD, analyzed 30 years of African-led clinical trials in cardiovascular medicine.
Pathology Office of Research Affairs Makes an Impact
Gina Della Porta, left, Director of the Office of Research Affairs, and David Stern, Professor of Pathology and Vice Chair for Basic and Translational Sciences, who oversees the office. In just one year, the Department of Pathology’s Office of Research Affairs has made an impact.
Electronic Health Record Strategies Can Improve Care of Patients with Heart Failure
Doctors frequently rely on the electronic health record (EHR) when caring for patients. Oftentimes, EHR systems will include clinical decision support tools that offer recommendations and reminders for physicians determining how to manage diagnosis or treatment plans.
Using Lessons from HIV to Treat Hepatitis C
A new study demonstrates how public health strategies aimed at improving HIV treatment outcomes can be used to better care for patients with another viral infection, hepatitis C. Hepatitis C is a deadly blood-borne disease that causes liver inflammation and scarring.
Yale Pepper Center Funding Available
The Yale Pepper Center is soliciting letters of intent from full-time faculty members at Yale with interests and expertise relevant to aging research who would be interested in submitting a career development proposal (if within 5 years of total faculty appointment) or a pilot project proposal.
Yale Older Adult Research Center Receives Renewed Funding
For the sixth consecutive time, the Yale Claude D. Pepper Older Americans Independence Center (OAIC) has been renewed for funding from the National Institute on Aging (NIA). The center is one of only two such programs nationwide that have received continuous NIA support since it was first funded in 1992.
Researchers Are Testing Paxlovid as a Treatment for Long COVID
Long COVID currently affects millions of people in the U.S. Symptoms can include brain fog, tremors, sleep disorders, and shortness of breath. The National Institutes of Health (NIH) and other academic medical centers recently launched clinical trials aimed at finding treatments for long COVID. Researchers think that there may be different causes of long COVID symptoms in different people, which is why they are conducting different clinical trials in many centers around the country.Source: Verywell Health
New Tools Enable Non-Clinicians to Diagnose Substance Use Disorders
A new study by Yale School of Medicine (YSM) and NYU Grossman School of Medicine researchers demonstrates the validity of two new diagnostic tools—the Rapid Opioid Use Disorder Assessment and the Rapid Stimulant Use Disorder Assessment. These instruments may be used to increase diagnoses of opioid and stimulant use disorder and access to treatment.
Yale researchers are working on a whole new type of vaccine, targeting the insects that carry pathogens
A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.Source: Stamford Advocate
25 Years of Sharing Scientific Findings
A major commitment of Women's Health Research at Yale is providing diverse audiences with new and accessible science-based information on women’s health and on how sex and gender influence health. The outlets for offering the translation of scientific findings have evolved over the years in its format and its content.